Hepatitis
Featured Article
Spring Bank Pharmaceuticals said it would not pursue further research and development efforts in chronic hepatitis B virus.
The FDA has issued a drug safety warning about the use of 3 medications for hepatitis C virus among individuals with moderate to severe liver impairment.
Researchers recently compared how the use of lipophilic or hydrophilic statins impacted hepatocellular carcinoma in patients with viral hepatitis.